Kinerase Debuts Targeted Anti-Aging Treatments, High-End SPF
This article was originally published in The Rose Sheet
Executive Summary
Valeant Pharmaceuticals is expanding its Kinerase portfolio this spring with products targeted to specific areas of the face where signs of aging are most noticeable, as well as a high-end moisturizer that will debut in doctor's offices